CTTN and hepatocellular carcinoma: The results showed that overexpression of CTTN increased numbers of self-renewing CSCs in trastuzumab-sensitive SKBR3 and BT474 cells, while knockdown of CTTN in trastuzumab-resistant JIMT-1 and HCC-1954 cells resulted in a reduction of CSC-like populations (Figure 2A).